OurPipeline
AdvancingmultipleindicationswithoursdRNAplatformtechnology
DevelopmentPipeline
Advancing multiple therapeutic programs across ophthalmology, dermatology, and systemic diseases
Discovery
Preclinical
Phase I
Phase II
Phase III
Ophthalmology
Persistent Corneal Epithelial Defect (PCED)
Glaucoma
Ocular Surface Disease
Retinal Disorders
Dermatology
Dermal Wound Healing
Systemic Disorders
Systemic Disorders
Discovery
Preclinical
Clinical Stages
MarketOpportunity
Global Impact
0B+
People with Vision Impairment Globally
$0B
Projected Ophthalmic Market by 2030
0+
Addressable Disease Indications
Platform Expansion
- 50+ diseases in the ocular anterior segment
- 12.5M patients with ocular surface disease
- Strong data for posterior segment diseases